Yourway Opens New Slovakia Location to Secure Client Trials in Case of No-Deal Brexit

Article

The new location was established to ensure uninterrupted support for clients’ trials in both the United Kingdom and Europe if the UK leaves the European Union on Oct. 31, 2019, especially in the event of a no-deal Brexit.

Yourway, a clinical packager based in Allentown, PA, announced the opening of a new location in Bratislava, Slovakia, for storage and distribution services and secondary packaging capabilities. The new location was established to ensure uninterrupted support for clients’ trials in both the United Kingdom and Europe if the UK leaves the European Union on Oct. 31, 2019, especially in the event of a no-deal Brexit, according to an Oct. 14, 2019 press release.

“The new location in Europe mitigates the uncertainty of Brexit for our clients, in order to service their clinical trial needs. It includes Qualified Person (QP) release services within Europe prior to release for use in a clinical trial, as required by Clinical Trial Directive 2001/20/EC and Annex 13 to the European GMP Guide,” said Gulam Jaffer, Yourway president and founder, in the press release.

The company provides temperature-controlled solutions designed to protect clinical trial shipments from the time an order is received through to delivery, according to the release. Yourway also offers a fast, integrated supply chain to meet the needs of the market.

“Through our Project Managers and QP release personnel, and use of our global network of GMP depots, we can assure safe and timely delivery of clinical trial materials to patients,” said Jaffer.

Source: Yourway

 

 

Recent Videos
Behind the Headlines episode 5
Lee Cronin, founder and CEO of Chemify
Pharm Tech Group looks at the challenges surrounding the development and manufacture of ATMPs in more detail with Agne Vaitkeviciene, CEO of Memel Biotech.
Pharm Tech Group sits down with Bernard Sagaert, CEO of etherna, to examine the role of mRNA in the treatment of autoimmune diseases.
Pharm Tech Group chats with Dr. Monika Paulė, CEO and co-founder of Caszyme about the evolution of CRISPR.
Related Content
© 2024 MJH Life Sciences

All rights reserved.